|
| 32051227 | Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses. | Sci Transl Med | 2020 |
| 32051227 | Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses. | Sci Transl Med | 2020 |
| 31395684 | Target Deconvolution of a Multikinase Inhibitor with Antimetastatic Properties Identifies TAOK3 as a Key Contributor to a Cancer Stem Cell-Like Phenotype. | Mol Cancer Ther | 2019 |
| 31395684 | Target Deconvolution of a Multikinase Inhibitor with Antimetastatic Properties Identifies TAOK3 as a Key Contributor to a Cancer Stem Cell-Like Phenotype. | Mol Cancer Ther | 2019 |
| 29769289 | Metarrestin, a perinucleolar compartment inhibitor, effectively suppresses metastasis. | Sci Transl Med | 2018 |
| 29769289 | Metarrestin, a perinucleolar compartment inhibitor, effectively suppresses metastasis. | Sci Transl Med | 2018 |
| 28401653 | Selective blockade of B7-H3 enhances antitumour immune activity by reducing immature myeloid cells in head and neck squamous cell carcinoma. | J Cell Mol Med | 2017 |
| 28460635 | Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer. | J Transl Med | 2017 |
| 28401653 | Selective blockade of B7-H3 enhances antitumour immune activity by reducing immature myeloid cells in head and neck squamous cell carcinoma. | J Cell Mol Med | 2017 |
| 28460635 | Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer. | J Transl Med | 2017 |
| 27132513 | TNF-α modulates genome-wide redistribution of οNp63α/TAp73 and NF-κB cREL interactive binding on TP53 and AP-1 motifs to promote an oncogenic gene program in squamous cancer. | Oncogene | 2016 |
| 27132513 | TNF-α modulates genome-wide redistribution of οNp63α/TAp73 and NF-κB cREL interactive binding on TP53 and AP-1 motifs to promote an oncogenic gene program in squamous cancer. | Oncogene | 2016 |
| 25798061 | MEK inhibitor PD-0325901 overcomes resistance to CK2 inhibitor CX-4945 and exhibits anti-tumor activity in head and neck cancer. | Int J Biol Sci | 2015 |
| 25798061 | MEK inhibitor PD-0325901 overcomes resistance to CK2 inhibitor CX-4945 and exhibits anti-tumor activity in head and neck cancer. | Int J Biol Sci | 2015 |
| 23455325 | Aberrant IKKα and IKKβ cooperatively activate NF-κB and induce EGFR/AP1 signaling to promote survival and migration of head and neck cancer. | Oncogene | 2014 |
| 25379016 | CK2 phosphorylates and inhibits TAp73 tumor suppressor function to promote expression of cancer stem cell genes and phenotype in head and neck cancer. | Neoplasia | 2014 |
| 24258200 | Epidermal overexpression of transgenic οNp63 promotes type 2 immune and myeloid inflammatory responses and hyperplasia via NF-κB activation. | J Pathol | 2014 |
| 23455325 | Aberrant IKKα and IKKβ cooperatively activate NF-κB and induce EGFR/AP1 signaling to promote survival and migration of head and neck cancer. | Oncogene | 2014 |
| 25379016 | CK2 phosphorylates and inhibits TAp73 tumor suppressor function to promote expression of cancer stem cell genes and phenotype in head and neck cancer. | Neoplasia | 2014 |
| 24258200 | Epidermal overexpression of transgenic οNp63 promotes type 2 immune and myeloid inflammatory responses and hyperplasia via NF-κB activation. | J Pathol | 2014 |
| 22641218 | TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers. | Oncogene | 2013 |
| 22641218 | TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers. | Oncogene | 2013 |
| 24124460 | Inhibition of mTOR reduces anal carcinogenesis in transgenic mouse model. | PLoS One | 2013 |
| 23640975 | PI3K/mTOR inhibitor PF-04691502 antitumor activity is enhanced with induction of wild-type TP53 in human xenograft and murine knockout models of head and neck cancer. | Clin Cancer Res | 2013 |
| 23421960 | Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signaling. | J Transl Med | 2013 |
| 23340180 | MicroRNA-135b acts as a tumor promoter by targeting the hypoxia-inducible factor pathway in genetically defined mouse model of head and neck squamous cell carcinoma. | Cancer Lett | 2013 |
| 24124460 | Inhibition of mTOR reduces anal carcinogenesis in transgenic mouse model. | PLoS One | 2013 |
| 23640975 | PI3K/mTOR inhibitor PF-04691502 antitumor activity is enhanced with induction of wild-type TP53 in human xenograft and murine knockout models of head and neck cancer. | Clin Cancer Res | 2013 |
| 23421960 | Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signaling. | J Transl Med | 2013 |
| 23340180 | MicroRNA-135b acts as a tumor promoter by targeting the hypoxia-inducible factor pathway in genetically defined mouse model of head and neck squamous cell carcinoma. | Cancer Lett | 2013 |
| 22037217 | Loss of TGF-β signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation. | Oncogene | 2012 |
| 22859719 | Chemopreventive and chemotherapeutic actions of mTOR inhibitor in genetically defined head and neck squamous cell carcinoma mouse model. | Clin Cancer Res | 2012 |
| 22037217 | Loss of TGF-β signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation. | Oncogene | 2012 |
| 22859719 | Chemopreventive and chemotherapeutic actions of mTOR inhibitor in genetically defined head and neck squamous cell carcinoma mouse model. | Clin Cancer Res | 2012 |
| 21576089 | οNp63 versatilely regulates a Broad NF-κB gene program and promotes squamous epithelial proliferation, migration, and inflammation. | Cancer Res | 2011 |
| 21576089 | οNp63 versatilely regulates a Broad NF-κB gene program and promotes squamous epithelial proliferation, migration, and inflammation. | Cancer Res | 2011 |
| 19584284 | Progressive tumor formation in mice with conditional deletion of TGF-beta signaling in head and neck epithelia is associated with activation of the PI3K/Akt pathway. | Cancer Res | 2009 |
| 19584284 | Progressive tumor formation in mice with conditional deletion of TGF-beta signaling in head and neck epithelia is associated with activation of the PI3K/Akt pathway. | Cancer Res | 2009 |
| 18075308 | Sensitive and quantitative detection of KRAS2 gene mutations in pancreatic duct juice differentiates patients with pancreatic cancer from chronic pancreatitis, potential for early detection. | Cancer Biol Ther | 2008 |
| 18075308 | Sensitive and quantitative detection of KRAS2 gene mutations in pancreatic duct juice differentiates patients with pancreatic cancer from chronic pancreatitis, potential for early detection. | Cancer Biol Ther | 2008 |
| 17890272 | Somatic acquisition of TGFBR1*6A by epithelial and stromal cells during head and neck and colon cancer development. | Hum Mol Genet | 2007 |
| 17890272 | Somatic acquisition of TGFBR1*6A by epithelial and stromal cells during head and neck and colon cancer development. | Hum Mol Genet | 2007 |
| 17534148 | TGF-beta receptor I conditional knockout mice develop spontaneous squamous cell carcinoma. | Cell Cycle | 2007 |
| 17534148 | TGF-beta receptor I conditional knockout mice develop spontaneous squamous cell carcinoma. | Cell Cycle | 2007 |
| 17106238 | Detecting low-abundance p16 and p53 mutations in pancreatic juice using a novel assay: heteroduplex analysis of limiting dilution PCRs. | Cancer Biol Ther | 2006 |
| 17106238 | Detecting low-abundance p16 and p53 mutations in pancreatic juice using a novel assay: heteroduplex analysis of limiting dilution PCRs. | Cancer Biol Ther | 2006 |
| 15860866 | TGFBR1*6A may contribute to hereditary colorectal cancer. | J Clin Oncol | 2005 |
| 15860866 | TGFBR1*6A may contribute to hereditary colorectal cancer. | J Clin Oncol | 2005 |
| 16204663 | Somatic acquisition and signaling of TGFBR1*6A in cancer. | JAMA | 2005 |
| 16204663 | Somatic acquisition and signaling of TGFBR1*6A in cancer. | JAMA | 2005 |